On February 9, the Zhejiang Happy Chinese New Year performance troupe brought its brilliant cultural showcase to Sweden, ...

Moleculin Biotech, Inc., ("Moleculin" or the "Company"), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced it ...

At this time, all participants are on a listen-only mode. A question-and-answer session will follow the formal presentation. ...

Pushkal Garg; Chief Medical Officer, Executive Vice President - Development and Medical Affairs; Alnylam Pharmaceuticals Inc Jeffrey Poulton; Chief Financial Officer, Executive Vice President; Alnylam ...

Thank you for standing by and welcome to the MKS Instruments fourth quarter 2024 earnings conference call. (Operator Instructions) As a reminder, today's program is being recorded. And now I'd like to ...

Agios Pharmaceuticals reported its fourth-quarter 2024 earnings, surpassing analysts' expectations with an earnings per share (EPS) of -$1.44 compared to the forecast of -$1.68. The company also ...